Kelly CRISPR & Gene Editi... (XDNA)
NASDAQ: XDNA
· Real-Time Price · USD
7.38
-0.12 (-1.60%)
At close: Nov 30, 2023, 5:51 PM
-1.60% (1D)
| Bid | - |
| Market Cap | 2.58M |
| AUM | 2.59M |
| NAV | 7.38 |
| EPS (ttm) | 0.00 |
| PE Ratio (ttm) | n/a |
| Shares Out | 350.21K |
| Inception Date | Jan 13, 2022 |
| Ask | - |
| Volume | 4.25K |
| Open | 7.53 |
| Previous Close | 7.50 |
| Day's Range | 7.38 - 7.55 |
| 52-Week Range | 5.87 - 11.83 |
| Holdings | 1 |
| Expense Ratio | 0.78% |
About XDNA
The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.
Asset Class Equity
Ticker Symbol XDNA
Inception Date Jan 13, 2022
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 100.00% of assets
| Name | Symbol | Weight |
|---|---|---|
| Cash & Other | Cash&Other | 100.00% |
Dividends Dividend Yield 0.09%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 22, 2022 | $0.0093 | Dec 27, 2022 |
3 years ago · etf.com
Kelly Debuts With Thematic ETFsThe first-time issuer started off as an index provider.
